Skip to main content
. 2021 Feb 26;43(1):391–400. doi: 10.1080/0886022X.2021.1891098

Figure 4.

Figure 4.

The role of exogenous miR-21 in promoting cardiomyocyte hypertrophy. The diameter of cell (A), protein concentration (B) and ANP content (C) of cardiomyocytes treated with normal medium, conditioned medium containing MVs, miR-21 inhibitor and MVs containing miR-21 inhibitor respectively. The transfection miRNA21 inhibitor efficiency (D) *p < 0.05 versus control.